However in B16-OVA melanoma cells, NRF2 knockout alone does not significantly inhibit primary tumor growth in the absence of anti-PD1 (Fig. 2e), nor does KEAP1 knockout enhance tumor growth in the absence of treatment (Fig. 2c, e and Supplementary Fig. 4A). Here, NFE2L2 is linked to melanoma.